ArticleTechnology in cancer research & treatment2018
Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-
Article in Technology in cancer research & treatment, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Modern Approaches for Thoracic Image Registration and Respiratory Motion Management in Oncology.Radiology. Imaging cancer · 2025Review
- Review
- Feasibility of simulation free abdominal stereotactic adaptive radiotherapy using an expedited pre-plan workflow.Physics and imaging in radiation oncology · 2024Article
- [Advances in magnetic resonance imaging guided radiation therapy].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2021Review
- Comparison of gross tumor volumes of pulmonary metastasis defined by CT and MRI in 0.345 T MRI-guided radiotherapy.BJR open · 2020Article
- Article
- Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques.Hematology/oncology clinics of North America · 2019Review
- Stereotactic Body Radiation Therapy and Ablative Therapies for Solid Tumors: Recent Advances and Clinical Applications.Technology in cancer research & treatment · 2019Article
- "Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era.Frontiers in oncology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTo evaluate the intra-/interobserver variability of gross target volumes between delineation based on magnetic resonance imaging and computed tomography in patients simulated for stereotactic body radiotherapy for primary lung cancer and lung metastasis. MATERIALS AND
methodsTwenty-five patients (27 lesions) who underwent computed tomography and magnetic resonance simulation with the MR-
resultsNo significant volumetric difference was observed between all 4 comparisons (GTV
conclusionNo significant differences in volumes between magnetic resonance- and computed tomograpghy-based Gross target volumes were found among 2 ROs. Magnetic resonance-based GTV delineation for lung stereotactic body radiotherapy also demonstrated acceptable interobserver agreement. Tumors >5 cm
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.